SpineCor® is a new breakthrough treatment for
idiopathic scoliosis utilising a dynamic corrective brace (DCB), clinical
assistant diagnostic software (SAS) and postural measurement equipment
(Freepoint). In worldwide clinical use, this new treatment has been shown
to be effective in 89% of cases (either by stabilisation or improvement in
(Cobb) angle of the curve).
The SpineCor® treatment approach
is completely different to that of traditional 3-point pressure rigid braces; it
is the first and only true dynamic bracing system for idiopathic
scoliosis. SpineCor®’s unique approach to treatment by global postural
re-education has been shown to give progressive correction over time which,
unlike any previous brace treatment, is extremely stable post brace
weaning.
Clinical experience to date also
shows better compliance and cosmetic results.
SpineCor®:
-
Allows patients four hours per
day out of brace
-
Allows total freedom of
movement
-
Offers better cosmesis under
clothing, and
-
Is cooler to wear.
With all of these benefits, it is
not difficult to see why compliance might be better than with bulky, rigid
braces that severely restrict movement and must be worn 23 hours per
day.
Although to date no specific
study has been undertaken to quantify cosmetic improvement, subjectively, some
striking improvements have been observed clinically. Additionally, some
very positive postural changes have been noted in cases where there has been no
change in Cobb angle.
Summary
SpineCor® offers:
-
A much more acceptable treatment to patients,
being cooler to wear, less restrictive, more easily concealed under clothing
and 4 hours of out of brace time per day.
-
No side effects. Rigid braces
cause muscle atrophy and can be harmful to normal development in a growing
child.
-
Excellent treatment results, particularly when
treatment is started early.
-
Excellent stability of treatment results post
bracing.
-
Neuromuscular integration for maintenance of
improved posture.
-
Potential to reduce incidence of surgical
intervention.
Conclusion
SpineCor® is a highly effective for the early
treatment of idiopathic scoliosis as demonstrated in the case
study and also offers significant benefits to patients who present
late. The real challenge is, therefore, to increase awareness of the
absolute importance of early diagnosis and, that a viable treatment for early
intervention is now available.